Skip to main content
Top
Published in: Angiogenesis 1/2007

01-03-2007 | Original Paper is

Regulation of endothelial cell migration by amphiphiles—are changes in cell membrane physical properties involved?

Authors: Lasse D. E. Jensen, Anker J. Hansen, Jens A. Lundbæk

Published in: Angiogenesis | Issue 1/2007

Login to get access

Abstract

Endothelial cell (EC) migration is an integral part of angiogenesis and a prerequisite for malignant tumor growth. Recent studies suggest that amphiphilic compounds can regulate migration of bovine aortic ECs by altering the physical properties of the cell membrane lipid bilayers. A number of structurally different amphiphiles thus regulate the migration in quantitative correlation with their effects on the plasma membrane microviscosity. Many amphiphiles that affect EC migration and angiogenesis alter the physical properties of lipid bilayers, suggesting that such a regulatory mechanism may be of general importance. To investigate this notion, we studied the effects of lysophospholipids that inhibit migration of bovine aortic ECs and decrease cell membrane microviscosity, and of other amphiphiles that decrease membrane microviscosity (Triton X-100, octyl-β-glucoside, arachidonic acid, docosahexaenoic acid, ETYA, capsaicin) on the migration of porcine aortic ECs. We further studied whether the enzyme secretory phospholipase A2 (sPLA2) would affect migration in accordance with the changes in membrane microviscosity induced by its hydrolysis products lysophospholipids and polyunsaturated fatty acids. Arachidonic acid, at low concentrations, promoted cell migration by a mechanism involving metabolic products of this compound. Apart from this effect, all the amphiphiles, as well as sPLA2, inhibited cell migration. A semi-quantitative analysis found a similar correlation between the effects on migration and on lipid bilayer stiffness measured using gramicidin channels as molecular force transducers. These results suggest that changes in cell membrane physical properties may generally contribute to the effects of amphiphiles on EC migration.
Footnotes
1
Characterizing changes in the physical properties of a lipid membrane by such measurements of microviscosity is not unproblematic, as will be described below. However, for the present a change in microviscosity will be taken to reflect that the membrane physical properties are altered.
 
2
Triton X-100 and octyl-β-glucoside decrease lipid bilayer stiffness measured using gramicidin channels in living cells [35], but amphiphile-induced changes in τ have not been quantitatively studied in cells. The comparison of the effects of amphiphiles on cell migration and on τ (shown in Fig. 8) therefore is based on gramicidin channel experiments done in dioleoylphosphatidylcholine/n-decane lipid bilayers. This becomes relevant, first, because of the problems involved in evaluating changes in membrane physics on the basis of the microviscosity, second because no other measures of such changes - even qualitatively - correlate with the effects on migration.
 
Literature
1.
2.
go back to reference Hoeben A, Landuyt B, Higley MS, Wildiers H, Van Oosterom AT, De Bruijn EE (2004) Vascular endothelial growth factors and angiogenesis. Pharmacol Rev 56:549–580PubMedCrossRef Hoeben A, Landuyt B, Higley MS, Wildiers H, Van Oosterom AT, De Bruijn EE (2004) Vascular endothelial growth factors and angiogenesis. Pharmacol Rev 56:549–580PubMedCrossRef
3.
go back to reference Gojova A, Barakat AI (2005) Vascular endothelial wound closure under shear stress: role of membrane fluidity and flow-sensitive ion channels. J Appl Physiol 98:2355–2362PubMedCrossRef Gojova A, Barakat AI (2005) Vascular endothelial wound closure under shear stress: role of membrane fluidity and flow-sensitive ion channels. J Appl Physiol 98:2355–2362PubMedCrossRef
4.
go back to reference Van Aalst JA, Burmeister W, Fox PL, Graham LM (2004) Alfa-tocopherol preserves endothelial cell migration in the presence of cell-oxidized lipoprotein by inhibiting changes in cell membrane fluidity. J Vasc Surg 39:229–237PubMedCrossRef Van Aalst JA, Burmeister W, Fox PL, Graham LM (2004) Alfa-tocopherol preserves endothelial cell migration in the presence of cell-oxidized lipoprotein by inhibiting changes in cell membrane fluidity. J Vasc Surg 39:229–237PubMedCrossRef
5.
go back to reference Ghosh PK, Vasanji A, Murugesan G, Eppell SJ, Graham LM, Fox PL (2002) Membrane microviscosity regulates endothelial cell motility. Nat Cell Biol 11:894–900CrossRef Ghosh PK, Vasanji A, Murugesan G, Eppell SJ, Graham LM, Fox PL (2002) Membrane microviscosity regulates endothelial cell motility. Nat Cell Biol 11:894–900CrossRef
6.
go back to reference Antoniotti S, Fiorio Pla A, Pregnolato S, Mottola A, Lovisolo D, Munaron L (2003) Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: A pharmacological approach. J Cellular Physiol 197:370–378CrossRef Antoniotti S, Fiorio Pla A, Pregnolato S, Mottola A, Lovisolo D, Munaron L (2003) Control of endothelial cell proliferation by calcium influx and arachidonic acid metabolism: A pharmacological approach. J Cellular Physiol 197:370–378CrossRef
7.
go back to reference Kanayasu-Toyoda T, Morita I, Murota S (1996) Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3) is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostagland Leukotr Essent Fatty Acids 54:319–325CrossRef Kanayasu-Toyoda T, Morita I, Murota S (1996) Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3) is a potent stimulator of endothelial cell migration on pretreatment in vitro. Prostagland Leukotr Essent Fatty Acids 54:319–325CrossRef
8.
go back to reference Sa G, Fox PL (1994) Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J Biol Chem 269:3219–3225PubMed Sa G, Fox PL (1994) Basic fibroblast growth factor-stimulated endothelial cell movement is mediated by a pertussis toxin-sensitive pathway regulating phospholipase A2 activity. J Biol Chem 269:3219–3225PubMed
9.
go back to reference Bogatcheva NV, Sergeeva MG, Dudek SM, Verin AD (2005) Arachidonic acid cascade in endothelial cell pathobiology. Microvasc Res 69:107–127PubMedCrossRef Bogatcheva NV, Sergeeva MG, Dudek SM, Verin AD (2005) Arachidonic acid cascade in endothelial cell pathobiology. Microvasc Res 69:107–127PubMedCrossRef
10.
go back to reference Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79:935–945PubMed Larsson SC, Kumlin M, Ingelman-Sundberg M, Wolk A (2004) Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 79:935–945PubMed
11.
go back to reference Beck R, Bertolino S, Abbot SE, Aaronson PI, Smirnov SV (1998) Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ Res 83:923–931PubMed Beck R, Bertolino S, Abbot SE, Aaronson PI, Smirnov SV (1998) Modulation of arachidonic acid release and membrane fluidity by albumin in vascular smooth muscle and endothelial cells. Circ Res 83:923–931PubMed
12.
go back to reference Stillwell W, Wassall SR (2003) Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 126:1–27PubMedCrossRef Stillwell W, Wassall SR (2003) Docosahexaenoic acid: membrane properties of a unique fatty acid. Chem Phys Lipids 126:1–27PubMedCrossRef
13.
go back to reference Bruno MJ, Koeppe RE II, Andersen OS (2005) Modification of gramicidin channel function by PUFAs depends on double-bond structure. Biophysical J 88:575A Bruno MJ, Koeppe RE II, Andersen OS (2005) Modification of gramicidin channel function by PUFAs depends on double-bond structure. Biophysical J 88:575A
14.
go back to reference Sutphen R, Krischer JP (2004) Lysophospholipids as potential biomarkers in ovarian cancer. Cancer Epidmiol Biomarkers Prev 13:1185–1191 Sutphen R, Krischer JP (2004) Lysophospholipids as potential biomarkers in ovarian cancer. Cancer Epidmiol Biomarkers Prev 13:1185–1191
15.
go back to reference Lundbæk JA, Andersen OS (1994) Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers. J Gen Physiol 104:645–673PubMedCrossRef Lundbæk JA, Andersen OS (1994) Lysophospholipids modulate channel function by altering the mechanical properties of lipid bilayers. J Gen Physiol 104:645–673PubMedCrossRef
16.
go back to reference Lundbæk JA, Birn P, Girshman J, Hansen AJ, Andersen OS (1996) Membrane stiffness and channel function. Biochemistry 35:3825–3830PubMedCrossRef Lundbæk JA, Birn P, Girshman J, Hansen AJ, Andersen OS (1996) Membrane stiffness and channel function. Biochemistry 35:3825–3830PubMedCrossRef
17.
go back to reference Lundbæk JA, Birn P, Hansen AJ, Søgaard R, Nielsen C, Girshman J, Bruno MJ, Tape SE, Egebjerg J, Greathouse DV, Mattice GL, Koeppe RE 2nd, Andersen OS (2004) Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of micelle-forming amphiphiles and cholesterol. J Gen Physiol 123:599–621PubMedCrossRef Lundbæk JA, Birn P, Hansen AJ, Søgaard R, Nielsen C, Girshman J, Bruno MJ, Tape SE, Egebjerg J, Greathouse DV, Mattice GL, Koeppe RE 2nd, Andersen OS (2004) Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of micelle-forming amphiphiles and cholesterol. J Gen Physiol 123:599–621PubMedCrossRef
18.
go back to reference Min JK, Han KY, Kim EC, Kim YM, Lee SW, Kim OH, Kim KW, Gho YS, Kwon YG (2004) Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res 64:644–651PubMedCrossRef Min JK, Han KY, Kim EC, Kim YM, Lee SW, Kim OH, Kim KW, Gho YS, Kwon YG (2004) Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res 64:644–651PubMedCrossRef
19.
go back to reference Mori A, Lehmann S, O’Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler H (2006) Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 66:3222–3229PubMedCrossRef Mori A, Lehmann S, O’Kelly J, Kumagai T, Desmond JC, Pervan M, McBride WH, Kizaki M, Koeffler H (2006) Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 66:3222–3229PubMedCrossRef
20.
go back to reference Meddings JB, Hogaboam CM, Tran K, Reynolds JD, Wallace JL (1991) Capsaicin effects on non-neuronal plasma membranes. Biochim Biophys Acta 1070:43–50PubMedCrossRef Meddings JB, Hogaboam CM, Tran K, Reynolds JD, Wallace JL (1991) Capsaicin effects on non-neuronal plasma membranes. Biochim Biophys Acta 1070:43–50PubMedCrossRef
21.
go back to reference Lundbæk JA, Birn P, Tape SE, Toombes GES, Søgaard R, Koeppe RE 2nd, Gruner SM, Hansen AJ, Andersen OS (2005) Capsaicin regulates voltage-dependent sodium channels by altering lipid bilayer elasticity. Mol Pharmacol 68:680–689PubMed Lundbæk JA, Birn P, Tape SE, Toombes GES, Søgaard R, Koeppe RE 2nd, Gruner SM, Hansen AJ, Andersen OS (2005) Capsaicin regulates voltage-dependent sodium channels by altering lipid bilayer elasticity. Mol Pharmacol 68:680–689PubMed
22.
go back to reference Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH (2005) The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 69:307–301PubMedCrossRef Su SJ, Yeh TM, Chuang WJ, Ho CL, Chang KL, Cheng HL, Liu HS, Cheng HL, Hsu PY, Chow NH (2005) The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 69:307–301PubMedCrossRef
23.
go back to reference Hwang TC, Koeppe RE 2nd, Andersen OS (2003) Genistein can modulate channel function by a phosphorylation-independent mechanism: Importance of hydrophobic mismatch and bilayer mechanics. Biochemistry 42:13646–13658PubMedCrossRef Hwang TC, Koeppe RE 2nd, Andersen OS (2003) Genistein can modulate channel function by a phosphorylation-independent mechanism: Importance of hydrophobic mismatch and bilayer mechanics. Biochemistry 42:13646–13658PubMedCrossRef
24.
go back to reference Murakami M, Kudo I (2002) Phospholipase A2. J Biochem 3:285–292 Murakami M, Kudo I (2002) Phospholipase A2. J Biochem 3:285–292
25.
go back to reference Bonventre JV (1992) Phospholipase A2 and signal transduction. J Am Soc Nephrol 3:128–150PubMed Bonventre JV (1992) Phospholipase A2 and signal transduction. J Am Soc Nephrol 3:128–150PubMed
26.
go back to reference Rizzo MT, Nguyen E, Aldo-Benson M, Lambeau G (2000) Secreted phospholipase A(2) induces vascular endothelial cell migration. Blood 96:3809–3815PubMed Rizzo MT, Nguyen E, Aldo-Benson M, Lambeau G (2000) Secreted phospholipase A(2) induces vascular endothelial cell migration. Blood 96:3809–3815PubMed
27.
go back to reference Brown M., Anderson KM, Patel H, Hopfinger J, Harris JE (1992) Eicosatetraynoic acid and arachidonic acic-induced changes in cell membrane fluidity consonant with differences in computer aided design-structures. Biochim Biophys Acta 1105:285–290PubMedCrossRef Brown M., Anderson KM, Patel H, Hopfinger J, Harris JE (1992) Eicosatetraynoic acid and arachidonic acic-induced changes in cell membrane fluidity consonant with differences in computer aided design-structures. Biochim Biophys Acta 1105:285–290PubMedCrossRef
28.
go back to reference Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW (2006) Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Brit J Cancer 94:842–853PubMedCrossRef Brown MD, Hart CA, Gazi E, Bagley S, Clarke NW (2006) Promotion of prostatic metastatic migration towards human bone marrow stoma by Omega 6 and its inhibition by Omega 3 PUFAs. Brit J Cancer 94:842–853PubMedCrossRef
29.
go back to reference Mizunati M, Asano M, Roy S, Okuda Y (1997) Omega 3 polyunsaturated fatty acids inhibit migration of human vascular smooth muscle cells in vitro. Life Sciences 61:269–274 Mizunati M, Asano M, Roy S, Okuda Y (1997) Omega 3 polyunsaturated fatty acids inhibit migration of human vascular smooth muscle cells in vitro. Life Sciences 61:269–274
30.
go back to reference Burk RR (1973) A factor from a transformed cell line that affects cell migration. PNAS 2:369–372CrossRef Burk RR (1973) A factor from a transformed cell line that affects cell migration. PNAS 2:369–372CrossRef
31.
go back to reference Dengler WA, Fiebig HH (1995) Development of a propidium iodide fluorescence assay for proliferation and cytotoxitity assays. Anticancer Drugs 6:522–532PubMedCrossRef Dengler WA, Fiebig HH (1995) Development of a propidium iodide fluorescence assay for proliferation and cytotoxitity assays. Anticancer Drugs 6:522–532PubMedCrossRef
32.
go back to reference Roberts MF, Deems RA, Dennis EA (1977) Chemical modification of the histidine residue in phospholipase A2 (Naja Naja Naja). A case of half site reactivity. J Biol Chem 252:2405–2411PubMed Roberts MF, Deems RA, Dennis EA (1977) Chemical modification of the histidine residue in phospholipase A2 (Naja Naja Naja). A case of half site reactivity. J Biol Chem 252:2405–2411PubMed
33.
go back to reference Rinken A, Harro J, Engstrom L, Oreland L (1998) Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes. Biochem Pharmacol 55:423–431PubMedCrossRef Rinken A, Harro J, Engstrom L, Oreland L (1998) Role of fluidity of membranes on the guanyl nucleotide-dependent binding of cholecystokinin-8S to rat brain cortical membranes. Biochem Pharmacol 55:423–431PubMedCrossRef
35.
go back to reference Søgaard R, Werge TM, Bertelsen C, Lundbye C, Madsen KL, Nielsen CH, Andersen MB, Lundbæk JA (2006) GABAA receptor function is regulated by lipid bilayer elasticity. Biochemistry 45:13118–13129PubMedCrossRef Søgaard R, Werge TM, Bertelsen C, Lundbye C, Madsen KL, Nielsen CH, Andersen MB, Lundbæk JA (2006) GABAA receptor function is regulated by lipid bilayer elasticity. Biochemistry 45:13118–13129PubMedCrossRef
36.
go back to reference Mcgiff JC (1991) Annu Rev Pharmacol Toxicol. Cytochrome P450 metabolism of arachidonic acid 31:339–369 Mcgiff JC (1991) Annu Rev Pharmacol Toxicol. Cytochrome P450 metabolism of arachidonic acid 31:339–369
37.
go back to reference Lundbæk JA (2006) Regulation of membrane protein function by the elasticity of the host lipid bilayer. A single molecule technology to measure the bilayer properties experienced by an embedded protein. J Phys Cond Matt 18:S1305–S1344CrossRef Lundbæk JA (2006) Regulation of membrane protein function by the elasticity of the host lipid bilayer. A single molecule technology to measure the bilayer properties experienced by an embedded protein. J Phys Cond Matt 18:S1305–S1344CrossRef
38.
go back to reference Navarro A, Andand-Apte B, Parat M (2004) A role for caveolae in cell migration. FASEB J 18:1801–1811PubMedCrossRef Navarro A, Andand-Apte B, Parat M (2004) A role for caveolae in cell migration. FASEB J 18:1801–1811PubMedCrossRef
39.
go back to reference Lee AG (1991) Lipids and their effects on membrane proteins: evidence against a role for fluidity. Prog Lipid Res 30:323–348PubMedCrossRef Lee AG (1991) Lipids and their effects on membrane proteins: evidence against a role for fluidity. Prog Lipid Res 30:323–348PubMedCrossRef
40.
go back to reference Lentz BR (1993) Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chem Phys Lipids 64:99–116PubMedCrossRef Lentz BR (1993) Use of fluorescent probes to monitor molecular order and motions within liposome bilayers. Chem Phys Lipids 64:99–116PubMedCrossRef
41.
go back to reference Muller JM, van Faassen EE, van Ginkel G (1994) Experimental support for a novel compound motion model for the time resolved fluorescence anisotropy decay of TMA-DPH in lipid vesicle bilayers. Chem Phys 185:393–404CrossRef Muller JM, van Faassen EE, van Ginkel G (1994) Experimental support for a novel compound motion model for the time resolved fluorescence anisotropy decay of TMA-DPH in lipid vesicle bilayers. Chem Phys 185:393–404CrossRef
42.
go back to reference McMahon HT, Gallop JL (2005) Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 438:590–596PubMedCrossRef McMahon HT, Gallop JL (2005) Membrane curvature and mechanisms of dynamic cell membrane remodelling. Nature 438:590–596PubMedCrossRef
43.
go back to reference Zimmerberg J, Kozlov MM (2006) How proteins produce cell membrane curvature. Nat Rev Mol Cell Biol 7:9–19PubMedCrossRef Zimmerberg J, Kozlov MM (2006) How proteins produce cell membrane curvature. Nat Rev Mol Cell Biol 7:9–19PubMedCrossRef
44.
go back to reference Seddon JM (1990) Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids. Biochim Biophys Acta 1031:1–69PubMed Seddon JM (1990) Structure of the inverted hexagonal (HII) phase, and non-lamellar phase transitions of lipids. Biochim Biophys Acta 1031:1–69PubMed
Metadata
Title
Regulation of endothelial cell migration by amphiphiles—are changes in cell membrane physical properties involved?
Authors
Lasse D. E. Jensen
Anker J. Hansen
Jens A. Lundbæk
Publication date
01-03-2007
Publisher
Kluwer Academic Publishers
Published in
Angiogenesis / Issue 1/2007
Print ISSN: 0969-6970
Electronic ISSN: 1573-7209
DOI
https://doi.org/10.1007/s10456-006-9060-y

Other articles of this Issue 1/2007

Angiogenesis 1/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.